Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific antibodies against CD3 and CD20

Bispecific antibodies against CD3 and CD20

US Patent 10544220 · Granted Jan 28, 2020

Estimated economic value: $4,317,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating cancer with a combination of an anti-VEGF antibody and an an2025
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of 2025
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of 2025
Antibodies that bind PSMA and gamma-delta T cell receptors2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Binding agents binding to EpCAM and CD1372025
Binding agents binding to EpCAM and CD1372025
Binding agents binding to EpCAM and CD1372025